Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Current Leases (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Current Leases for 4 consecutive years, with $4.9 million as the latest value for Q2 2025.

  • Quarterly Current Leases rose 33.61% to $4.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Jun 2025, up 33.61% year-over-year, with the annual reading at $4.9 million for FY2024, 221.88% up from the prior year.
  • Current Leases for Q2 2025 was $4.9 million at Century Therapeutics, roughly flat from $4.9 million in the prior quarter.
  • The five-year high for Current Leases was $4.9 million in Q2 2025, with the low at $475000.0 in Q4 2022.
  • Average Current Leases over 4 years is $3.1 million, with a median of $3.7 million recorded in 2024.
  • The sharpest move saw Current Leases surged 221.88% in 2024, then skyrocketed 33.61% in 2025.
  • Over 4 years, Current Leases stood at $475000.0 in 2022, then soared by 218.53% to $1.5 million in 2023, then soared by 221.88% to $4.9 million in 2024, then grew by 0.49% to $4.9 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $4.9 million, $4.9 million, and $4.9 million for Q2 2025, Q1 2025, and Q4 2024 respectively.